Bio-responsive delivery of tissue plasminogen activator for localized thrombolysis

Journal of Controlled Release

Volumn 177, Issue 1, 2014, Pages 42-50

  Absar, Shahriar ^a   Kwon, Young M ^a,b   Ahsan, Fakhrul ^a  

^a TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^b NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Albumin based delivery; Protein delivery; Responsive delivery system; Targeted thrombolysis; Tissue plasminogen activator; Triggered release

Indexed keywords

ALBUMIN-BASED DELIVERY; PROTEIN DELIVERY; RESPONSIVE DELIVERY SYSTEMS; TARGETED THROMBOLYSIS; TISSUE PLASMINOGEN ACTIVATOR; TRIGGERED RELEASE;

AMINO ACIDS; BINDING ENERGY; BLOOD VESSELS; PEPTIDES; PLATELETS; TISSUE;

ENZYMES;

CYSTEINE; HUMAN SERUM ALBUMIN; IODOACETAMIDE; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BLOOD CLOT LYSIS; CONFERENCE PAPER; CONJUGATION; DEEP VEIN THROMBOSIS; DRUG DELIVERY SYSTEM; ENZYME REPRESSION; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC CIRCULATION; THROMBOCYTE ACTIVATION; THROMBOSIS;

ALBUMIN-BASED DELIVERY; PROTEIN DELIVERY; RESPONSIVE DELIVERY SYSTEM; TARGETED THROMBOLYSIS; TISSUE PLASMINOGEN ACTIVATOR; TRIGGERED RELEASE;

ANIMALS; FIBRINOGEN; FIBRINOLYTIC AGENTS; PEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; SERUM ALBUMIN; THROMBOLYTIC THERAPY; TISSUE PLASMINOGEN ACTIVATOR; VENOUS THROMBOSIS;

EID: 84892686737     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.12.036     Document Type: Conference Paper

References (43)

1. Y. Bae, N. Nishiyama, and K. Kataoka In vivo antitumor activity of the folate-conjugated pH-sensitive polymeric micelle selectively releasing adriamycin in the intracellular acidic compartments Bioconjug. Chem. 18 2007 1131 1139
2. S.M. Lee, H. Chen, C.M. Dettmer, T.V. O'Halloran, and S.T. Nguyen Polymer-caged liposomes: a pH-responsive delivery system with high stability J. Am. Chem. Soc. 129 2007 15096 15097
3. G.B. Sukhorukov, A.L. Rogach, M. Garstka, S. Springer, W.J. Parak, A. Munoz-Javier, O. Kreft, A.G. Skirtach, A.S. Susha, Y. Ramaye, R. Palankar, and M. Winterhalter Multifunctionalized polymer microcapsules: novel tools for biological and pharmacological applications Small 3 2007 944 955
4. M.P. Xiong, Y. Bae, S. Fukushima, M.L. Forrest, N. Nishiyama, K. Kataoka, and G.S. Kwon pH-Responsive multi-PEGylated dual cationic nanoparticles enable charge modulations for safe gene delivery ChemMedChem 2 2007 1321 1327
5. G.H. Gao, Y. Li, and D.S. Lee Environmental pH-sensitive polymeric micelles for cancer diagnosis and targeted therapy J. Control. Release 169 2013 180 184
6. M. Shen, Y. Huang, L. Han, J. Qin, X. Fang, J. Wang, and V.C. Yang Multifunctional drug delivery system for targeting tumor and its acidic microenvironment J. Control. Release 161 2012 884 892
7. F. Meng, Z. Zhong, and J. Feijen Stimuli-responsive polymersomes for programmed drug delivery Biomacromolecules 10 2009 197 209
8. A. Napoli, M.J. Boerakker, N. Tirelli, R.J. Nolte, N.A. Sommerdijk, and J.A. Hubbell Glucose-oxidase based self-destructing polymeric vesicles Langmuir 20 2004 3487 3491
9. S. Cajot, N. Lautram, C. Passirani, and C. Jerome Design of reversibly core cross-linked micelles sensitive to reductive environment J. Control. Release 152 2011 30 36
10. X. Tong, G. Wang, A. Soldera, and Y. Zhao How can azobenzene block copolymer vesicles be dissociated and reformed by light? J. Phys. Chem. B 109 2005 20281 20287
11. R. de la Rica, D. Aili, and M.M. Stevens Enzyme-responsive nanoparticles for drug release and diagnostics Adv. Drug Deliv. Rev. 64 2012 967 978
12. J. Patterson, and J.A. Hubbell SPARC-derived protease substrates to enhance the plasmin sensitivity of molecularly engineered PEG hydrogels Biomaterials 32 2011 1301 1310
13. T.L. Andresen, J. Davidsen, M. Begtrup, O.G. Mouritsen, and K. Jorgensen Enzymatic release of antitumor ether lipids by specific phospholipase A2 activation of liposome-forming prodrugs J. Med. Chem. 47 2004 1694 1703
14. D. Aili, and M.M. Stevens Bioresponsive peptide-inorganic hybrid nanomaterials Chem. Soc. Rev. 39 2010 3358 3370
15. L. Liang, S.W. Lin, W. Dai, J.K. Lu, T.Y. Yang, Y. Xiang, Y. Zhang, R.T. Li, and Q. Zhang Novel cathepsin B-sensitive paclitaxel conjugate: higher water solubility, better efficacy and lower toxicity J. Control. Release 160 2012 618 629
16. M.J. Vicent, F. Greco, R.I. Nicholson, A. Paul, P.C. Griffiths, and R. Duncan Polymer therapeutics designed for a combination therapy of hormone-dependent cancer Angew. Chem. Int. Ed. Engl. 44 2005 4061 4066
17. R. Satchi, T.A. Connors, and R. Duncan PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination Br. J. Cancer 85 2001 1070 1076
18. M.T. Basel, T.B. Shrestha, D.L. Troyer, and S.H. Bossmann Protease-sensitive, polymer-caged liposomes: a method for making highly targeted liposomes using triggered release ACS Nano 5 2011 2162 2175
19. C. Park, H. Kim, S. Kim, and C. Kim Enzyme responsive nanocontainers with cyclodextrin gatekeepers and synergistic effects in release of guests J. Am. Chem. Soc. 131 2009 16614 16615
20. A. Bernardos, L. Mondragon, E. Aznar, M.D. Marcos, R. Martinez-Manez, F. Sancenon, J. Soto, J.M. Barat, E. Perez-Paya, C. Guillem, and P. Amoros Enzyme-responsive intracellular controlled release using nanometric silica mesoporous supports capped with "saccharides" ACS Nano 4 2010 6353 6368
21. D. Collen, D.C. Stump, and H.K. Gold Thrombolytic therapy Annu. Rev. Med. 39 1988 405 423
22. K. Stangl, M. Laule, B. Tenckhoff, V. Stangl, V. Gliech, P. Dubel, A. Grohmann, C. Melzer, J. Langel, K.D. Wernecke, G. Baumann, and S. Ziemer Fibrinogen breakdown, long-lasting systemic fibrinolysis, and procoagulant activation during alteplase double-bolus regimen in acute myocardial infarction Am. J. Cardiol. 81 1998 841 847
23. A comparison of reteplase with alteplase for acute myocardial infarction. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators N. Engl. J. Med. 337 1997 1118 1123
24. D.F. Chapman, P. Lyden, P.A. Lapchak, S. Nunez, H. Thibodeaux, and J. Zivin Comparison of TNK with wild-type tissue plasminogen activator in a rabbit embolic stroke model Stroke 32 2001 748 752
25. G. Lippi, C. Mattiuzzi, and E.J. Favaloro Novel and emerging therapies: thrombus-targeted fibrinolysis Semin. Thromb. Hemost. 39 2013 48 58
26. V.C. Yang, S.S. Naik, H. Song, A.A. Dombkowski, G. Crippen, and J.F. Liang Construction and characterization of a t-PA mutant for use in ATTEMPTS: a drug delivery system for achieving targeted thrombolysis J. Control. Release 110 2005 164 176
27. Y. Uesugi, H. Kawata, J. Jo, Y. Saito, and Y. Tabata An ultrasound-responsive nano delivery system of tissue-type plasminogen activator for thrombolytic therapy J. Control. Release 147 2010 269 277
28. S.T. Laing, M.R. Moody, H. Kim, B. Smulevitz, S.L. Huang, C.K. Holland, D.D. McPherson, and M.E. Klegerman Thrombolytic efficacy of tissue plasminogen activator-loaded echogenic liposomes in a rabbit thrombus model Thromb. Res. 130 2012 629 635
29. K.E. Hitchcock, D.N. Caudell, J.T. Sutton, M.E. Klegerman, D. Vela, G.J. Pyne-Geithman, T. Abruzzo, P.E. Cyr, Y.J. Geng, D.D. McPherson, and C.K. Holland Ultrasound-enhanced delivery of targeted echogenic liposomes in a novel ex vivo mouse aorta model J. Control. Release 144 2010 288 295
30. S. Absar, S. Choi, F. Ahsan, E. Cobos, V.C. Yang, and Y.M. Kwon Preparation and characterization of anionic oligopeptide-modified tissue plasminogen activator for triggered delivery: an approach for localized thrombolysis Thromb. Res. 131 2012 e91 e99
31. S. Absar, S. Choi, V.C. Yang, and Y.M. Kwon Heparin-triggered release of camouflaged tissue plasminogen activator for targeted thrombolysis J. Control. Release 157 2012 46 54
32. S. Absar, K. Nahar, Y.M. Kwon, and F. Ahsan Thrombus-targeted nanocarrier attenuates bleeding complications associated with conventional thrombolytic therapy Pharm. Res. 30 2013 1663 1676
33. M. Tanihara, Y. Suzuki, Y. Nishimura, K. Suzuki, and Y. Kakimaru Thrombin-sensitive peptide linkers for biological signal-responsive drug release systems Peptides 19 1998 421 425
34. S. Ware, J.P. Donahue, J. Hawiger, and W.F. Anderson Structure of the fibrinogen gamma-chain integrin binding and factor XIIIa cross-linking sites obtained through carrier protein driven crystallization Protein Sci. 8 1999 2663 2671
35. S. Absar, K. Nahar, S. Choi, F. Ahsan, V.C. Yang, and Y.M. Kwon Serum albumin-protamine conjugate for biocompatible platform for targeted delivery of therapeutic macromolecules J. Biomed. Mater. Res. A 2013 10.1002/jbm.a.34916
36. M.M. Mir, K.M. Fazili, and M. Abul Qasim Chemical modification of buried lysine residues of bovine serum albumin and its influence on protein conformation and bilirubin binding Biochim. Biophys. Acta 1119 1992 261 267
37. S. Zaitsev, D. Spitzer, J.C. Murciano, B.S. Ding, S. Tliba, M.A. Kowalska, O.A. Marcos-Contreras, A. Kuo, V. Stepanova, J.P. Atkinson, M. Poncz, D.B. Cines, and V.R. Muzykantov Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation Blood 115 2010 5241 5248
38. A.S. Gupta, G. Huang, B.J. Lestini, S. Sagnella, K. Kottke-Marchant, and R.E. Marchant RGD-modified liposomes targeted to activated platelets as a potential vascular drug delivery system Thromb. Haemost. 93 2005 106 114
39. B.L. Eppley, W.S. Pietrzak, and M. Blanton Platelet-rich plasma: a review of biology and applications in plastic surgery Plast. Reconstr. Surg. 118 2006 147e 159e
40. S.S. Naik, J.F. Liang, Y.J. Park, W.K. Lee, and V.C. Yang Application of "ATTEMPTS" for drug delivery J. Control. Release 101 2005 35 45
41. K.D. Kurz, B.W. Main, and G.E. Sandusky Rat model of arterial thrombosis induced by ferric chloride Thromb. Res. 60 1990 269 280
42. M. Hiscock Percutaneous coronary intervention or prehospital thrombolysis? What is the preferred treatment in S-T elevation myocardial infarction? Intern. Med. J. 42 Suppl. 5 2012 44 46
43. A.S. Wolberg Thrombin generation and fibrin clot structure Blood Rev. 21 2007 131 142